Preferred Label : brigatinib;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3201262/fr/alunbrig
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
brigatinib
carcinoma, non-small-cell lung
ALK Inhibitor
Anaplastic Lymphoma Kinase
antineoplastic agents
protein kinase inhibitors
adult
brigatinib
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
brigatinib
organophosphorus compounds
pyrimidines

---
https://www.has-sante.fr/jcms/p_3118131/fr/alunbrig
2019
false
false
false
France
brigatinib
brigatinib
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
carcinoma, non-small-cell lung
administration, oral
bronchial neoplasms
evaluation of the transparency committee
brigatinib
organophosphorus compounds
pyrimidines

---
Nous contacter.
09/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.